Fragment-based molecular docking in inhibitor discovery against CTX-M class A β-lactamase

被引:0
|
作者
Chen, Yu [1 ]
Shoichet, Brian [2 ]
机构
[1] UCSF, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
26-COMP
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Discovery of a Novel Acetylcholinesterase Inhibitor by Fragment-Based Design and Virtual Screening
    Stavrakov, Georgi
    Philipova, Irena
    Lukarski, Atanas
    Atanasova, Mariyana
    Georgiev, Borislav
    Atanasova, Teodora
    Konstantinov, Spiro
    Doytchinova, Irini
    MOLECULES, 2021, 26 (07):
  • [22] Development of Dual Inhibitors against Alzheimer's Disease Using Fragment-Based QSAR and Molecular Docking
    Goyal, Manisha
    Dhanjal, Jaspreet Kaur
    Goyal, Sukriti
    Tyagi, Chetna
    Hamid, Rabia
    Grover, Abhinav
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [23] Mutation of the conserved Asp-Asp pair impairs the structure, function, and inhibition of CTX-M Class A β-lactamase
    Kemp, M. Trent
    Nichols, Derek A.
    Zhang, Xiujun
    Defrees, Kyle
    Na, Insung
    Renslo, Adam R.
    Chen, Yu
    FEBS LETTERS, 2021, 595 (24) : 2981 - 2994
  • [24] The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening
    Vella, Peter
    Hussein, Waleed M.
    Leung, Eleanor W. W.
    Clayton, Daniel
    Ollis, David L.
    Mitic, Natasa
    Schenk, Gerhard
    McGeary, Ross P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (11) : 3282 - 3285
  • [25] CTX-M β-lactamase-producing Escherichia coli in French hospitals:: Prevalence, molecular epidemiology, and risk factors
    Lavigne, Jean-Philippe
    Marchandin, Helene
    Delmas, Julien
    Moreau, Jerome
    Bouziges, Nicole
    Lecaillon, Evelyne
    Cavalie, Laurent
    Jean-Pierre, Helene
    Bonnet, Richard
    Sotto, Albert
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) : 620 - 626
  • [26] FAME: Fragment-based Conditional Molecular Generation for Phenotypic Drug Discovery
    Thai-Hoang Pham
    Xie, Lei
    Zhang, Ping
    PROCEEDINGS OF THE 2022 SIAM INTERNATIONAL CONFERENCE ON DATA MINING, SDM, 2022, : 720 - 728
  • [27] Balancing target flexibility and target denaturation in computational fragment-based inhibitor discovery
    Foster, Theresa J.
    MacKerell, Alexander D., Jr.
    Guvench, Olgun
    JOURNAL OF COMPUTATIONAL CHEMISTRY, 2012, 33 (23) : 1880 - 1891
  • [28] A fragment-based drug discovery strategy applied to the identification of NDM-1 β-lactamase inhibitors
    Caburet, Jeremy
    Boucherle, Benjamin
    Bourdillon, Sofiane
    Simoncelli, Giorgia
    Verdirosa, Federica
    Docquier, Jean-Denis
    Moreau, Yohann
    Krimm, Isabelle
    Crouzy, Serge
    Peuchmaur, Marine
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
  • [29] Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification
    Thomas, Sherine E.
    Whitehouse, Andrew J.
    Brown, Karen
    Burbaud, Sophie
    Belardinelli, Juan M.
    Sangen, Jasper
    Lahiri, Ramanuj
    Libardo, Mark Daben J.
    Gupta, Pooja
    Malhotra, Sony
    Boshoff, Helena I. M.
    Jackson, Mary
    Abell, Chris
    Coyne, Anthony G.
    Blundell, Tom L.
    Floto, Rodrigo Andres
    Mendes, Vitor
    NUCLEIC ACIDS RESEARCH, 2020, 48 (14) : 8099 - 8112
  • [30] Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton's Tyrosine Kinase
    Smith, Christopher R.
    Dougan, Douglas R.
    Komandla, Mallareddy
    Kanouni, Toufike
    Knight, Beverly
    Lawson, J. David
    Sabat, Mark
    Taylor, Ewan R.
    Phong Vu
    Wyrick, Corey
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (14) : 5437 - 5444